Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

GATA2 Mutations in Pediatric Acute Myeloid Leukemia: A Study of the Japanese Childhood AML Cooperative Study Group.

Norio Shiba, MD, Kentarou Ohki, MD, Myoung-ja Park, MD, PhD, Souichi Adachi, MD, PhD, Masao Kobayashi, MD, PhD, Akitoshi Kinoshita, MD, Manabu Sotomatsu, MD, Hirokazu Arakawa, MD, PhD, Akio Tawa, MD, PhD, Keizo Horibe, MD, PhD, Ichiro Tsukimoto, MD., PhD, Yasuhide Hayashi, MD, PhD

Blood (2012) 120 (21): 2536.

https://doi.org/10.1182/blood.V120.21.2536.2536

Published: 2012

Journal Articles

NUP98-NSD1 Related Gene Expression Signature Is Strongly Associated with a Poor Prognosis in Pediatric Acute Myeloid Leukemia

Norio Shiba, MD, Hitoshi Ichikawa, PhD, Tomohiko Taki, MD, PhD, Myoung-ja Park, MD, PhD, Aoi Jo, MD, Sachiyo Mitani, BSc, Tohru Kobayashi, MD, PhD, Akira Shimada, MD, PhD, Manabu Sotomatsu, MD, Hirokazu Arakawa, MD, PhD, Souichi Adachi, MD, PhD, Akio Tawa, MD, PhD, Keizo Horibe, MD, Masahiro Tsuchida, MD, PhD, Ryoji Hanada, MD, Ichiro Tsukimoto, MD., PhD, Yasuhide Hayashi, MD, PhD

Blood (2012) 120 (21): 1391.

https://doi.org/10.1182/blood.V120.21.1391.1391

Published: 2012

Journal Articles

Heterogeneity in Infants with Acute Myeloid Leukemia: Retrospective Analysis of a Japanese Nationwide Survey

Akira Shimada, MD, PhD, Daisuke Tomizawa, MD, Akitoshi Kinoshita, MD, PhD, Kazuko Hamamoto, MD., PhD, Ichiro Tsukimoto, MD., PhD, Atsushi Ogawa, MD, Takashi Taga, MD, PhD, Toshihiko Imamura, MD, PhD, Akio Tawa, MD, PhD, Keizo Horibe, MD, PhD, Tomohiko Taki, MD, PhD, Yasuhide Hayashi, MD, PhD, Souichi Adachi, MD, PhD

Blood (2011) 118 (21): 1477.

https://doi.org/10.1182/blood.V118.21.1477.1477

Published: 2011

Journal Articles

NUP98-NSD1 Fusion Gene Is Strongly Associated with a Poor Prognosis in Pediatric Acute Myeloid Leukemia: A Study of the Japanese Childhood AML99 Cooperative Study Group

Norio Shiba, MD, Tomohiko Taki, MD, PhD, Myoung-ja Park, MD, PhD, Chisato Murata, PhD, Kentaro Oki, MD, Hitoshi Ichikawa, PhD, Akira Shimada, MD, PhD, Takashi Kanazawa, MD, PhD, Manabu Sotomatsu, MD, Ken Tabuchi, MD, Souichi Adachi, MD, PhD, Akio Tawa, MD, PhD, Keizo Horibe, MD, PhD, Masahiro Tsuchida, MD, PhD, Ryoji Hanada, MD, Ichiro Tsukimoto, MD., PhD, Hirokazu Arakawa, MD, PhD, Yasuhide Hayashi, MD, PhD

Blood (2011) 118 (21): 1475.

https://doi.org/10.1182/blood.V118.21.1475.1475

Published: 2011

Journal Articles

Age-Associated Difference in Gene Expression of Pediatric Myelo-Monocytic and MLL -Rearranged AML.

Aoi Jo, MD, Ichiro Tsukimoto, MD, PhD, Eiichi Ishii, MD, PhD, Norio Asou, MD, PhD, Takashi Igarashi, MD, PhD, Yasuhide Hayashi, MD, PhD, Hitoshi Ichikawa, PhD

Blood (2007) 110 (11): 3164.

https://doi.org/10.1182/blood.V110.11.3164.3164

Published: 2007

Journal Articles

10-Year-Outcome of Acquired Aplastic Anemia Children Treated with Antithymocyte Globulin, Cyclosporine with or without G-CSF.

Akira Ohara, MD, Seiji Kojima, MD, Ryoji Kobayashi, MD, Yoshiyuki Kosaka, MD, Shoichi Ohga, MD, Kanji Sugita, MD, Hiromasa Yabe, MD, Masahiro Tsuchida, MD, Fumio Bessho, MD, Hideo Mugishima, MD, Ichiro Tsukimoto, MD, Tatsutoshi Nakahata

Blood (2006) 108 (11): 126.

https://doi.org/10.1182/blood.V108.11.126.126

Published: 2006

Journal Articles

The Prognosis of Karyotypic Subgroups in Pediatric Acute Myeloid Leukemia Depends on the Alterations of KIT , MLL and FLT3 Genes: A Report from Japanese Childhood AML Cooperative Study Group.

Akira Shimada, MD, Tomohiko Taki, MD, Ken Tabuchi, MD, Ryoji Hanada, MD, Akio Tawa, MD, Masahiro Tsuchida, MD, Keizo Horibe, MD, Ichiro Tsukimoto, MD, Yasuhide Hayashi, MD

Blood (2006) 108 (11): 2281.

https://doi.org/10.1182/blood.V108.11.2281.2281

Published: 2006

Journal Articles

Tandem Duplications of the FLT3 and MLL Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia. AML99 Study in Japan.

Akira Shimada, MD, Tomohiko Taki, MD, Ken Tabuchi, MD, Takeshi Taketani, MD, Ryoji Hanada, MD, Akio Tawa, MD, Masahiro Tsuchida, MD, Keizo Horibe, MD, Ichiro Tsukimoto, MD, Yasuhide Hayashi, MD

Blood (2005) 106 (11): 2779.

https://doi.org/10.1182/blood.V106.11.2779.2779

Published: 2005

Journal Articles

Repetitive Cycles of High-Dose Cytarabine Are Effective for Childhood Acute Myeloid Leukemia (AML): Long Term Outcome of the Children with AML Treated on Two Consecutive Trials of Tokyo Children’s Cancer Study Group.

Daisuke Tomizawa, MD, Ken Tabuchi, MD, Akitoshi Kinoshita, MD, Ryoji Hanada, MD, Hisato Kigasawa, MD, Ichiro Tsukimoto, MD, Masahiro Tsuchida, MD

Blood (2005) 106 (11): 888.

https://doi.org/10.1182/blood.V106.11.888.888

Published: 2005

Journal Articles

Excellent Outcome of Risk Stratified Treatment for Childhood Acute Myeloid Leukemia-AML99 Trial. For the Japanese Childhood AML Cooperative Study Group.

Ichiro Tsukimoto, MD, Akio Tawa, MD, Ryoji Hanada, MD, Ken Tabuchi, MD, Hisato Kigasawa, MD, Shigeru Tsuchiya, MD, Masahiro Tsuchida, MD, Hiromasa Yabe, MD, Hideki Nakayama, MD, Kazuko Kudo, MD, Ryoji Kobayashi, MD, Kazuko Hamamoto, MD, Masue Imaizumi, MD, Akira Morimoto, MD, Keizo Horibe, MD

Blood (2005) 106 (11): 889.

https://doi.org/10.1182/blood.V106.11.889.889

Published: 2005

Journal Articles

Improved Outcome of Combination Therapy with ATRA, Anthracyclines and Cytarabine, AML99-M3 Protocol, for Childhood Acute Promyelocytic Leukemia.

Masue Imaizumi, MD, Akio Tawa, MD, Ryoji Hanada, MD, Masahiro Tsuchida, MD, Ken Taguchi, MD, Ryoji Kobayashi, MD, Akira Morimoto, MD, Hideki Nakayama, MD, Kazuko Hamamoto, MD, Kazuko Kudo, MD, Hiromasa Yabe, MD, Hisato Kigasawa, MD, Keizo Horibe, MD, Shigeru Tsuchiya, MD, Ichiro Tsukimoto, MD

Blood (2005) 106 (11): 891.

https://doi.org/10.1182/blood.V106.11.891.891

Published: 2005

Journal Articles

Prospective, Randomized, Multicenter Study Comparing Antithymocyte Globulin (ATG) Alone with ATG Plus Cyclosporine (CsA) for Treatment of Children with Nonsevere Aplastic Anemia (nSAA).

Hiroshi Yagasaki, MD, Hiromasa Yabe, MD, Hiroshi Ayukawa, MD, Yasushi Noguchi, MD, Osamu Ijichi, MD, Ryoji Kobayashi, MD, Masahiro Tsuchida, MD, Hideo Mugishima, MD, Akira Ohara, MD, Akira Morimoto, MD, Shouichi Oga, MD, Fumio Bessho, MD, Tatsutoshi Nakahata, MD, Ichiro Tsukimoto, MD, Seiji Kojima, MD

Blood (2005) 106 (11): 1043.

https://doi.org/10.1182/blood.V106.11.1043.1043

Published: 2005

Journal Articles

Internal Tandem Duplication and Kinase Domain Mutation of FLT3 in Pediatric Acute Myeloid Leukemia Treated on Japan Cooperative AML 99 Protocol.

Akira Shimada, MD, Takeshi Taketani, MD, Tomohiko Taki, MD, Ken Tabuchi, MD, Ryoji Hanada, MD, Akio Tawa, MD, Masahiro Tsuchida, MD, Keizo Horibe, MD, Ichiro Tsukimoto, MD, Yasuhide Hayashi, MD

Blood (2004) 104 (11): 3010.

https://doi.org/10.1182/blood.V104.11.3010.3010

Published: 2004

NARROW

GATA2 Mutations in Pediatric Acute Myeloid Leukemia: A Study of the Japanese Childhood AML Cooperative Study Group.

NUP98-NSD1 Related Gene Expression Signature Is Strongly Associated with a Poor Prognosis in Pediatric Acute Myeloid Leukemia

Heterogeneity in Infants with Acute Myeloid Leukemia: Retrospective Analysis of a Japanese Nationwide Survey

NUP98-NSD1 Fusion Gene Is Strongly Associated with a Poor Prognosis in Pediatric Acute Myeloid Leukemia: A Study of the Japanese Childhood AML99 Cooperative Study Group

Age-Associated Difference in Gene Expression of Pediatric Myelo-Monocytic and MLL -Rearranged AML.

10-Year-Outcome of Acquired Aplastic Anemia Children Treated with Antithymocyte Globulin, Cyclosporine with or without G-CSF.

The Prognosis of Karyotypic Subgroups in Pediatric Acute Myeloid Leukemia Depends on the Alterations of KIT , MLL and FLT3 Genes: A Report from Japanese Childhood AML Cooperative Study Group.

Tandem Duplications of the FLT3 and MLL Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia. AML99 Study in Japan.

Repetitive Cycles of High-Dose Cytarabine Are Effective for Childhood Acute Myeloid Leukemia (AML): Long Term Outcome of the Children with AML Treated on Two Consecutive Trials of Tokyo Children’s Cancer Study Group.

Excellent Outcome of Risk Stratified Treatment for Childhood Acute Myeloid Leukemia-AML99 Trial. For the Japanese Childhood AML Cooperative Study Group.

Improved Outcome of Combination Therapy with ATRA, Anthracyclines and Cytarabine, AML99-M3 Protocol, for Childhood Acute Promyelocytic Leukemia.

Prospective, Randomized, Multicenter Study Comparing Antithymocyte Globulin (ATG) Alone with ATG Plus Cyclosporine (CsA) for Treatment of Children with Nonsevere Aplastic Anemia (nSAA).

Internal Tandem Duplication and Kinase Domain Mutation of FLT3 in Pediatric Acute Myeloid Leukemia Treated on Japan Cooperative AML 99 Protocol.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only